Model
Edge
Alnylam Pharmaceuticals, Inc.
0001782962
Filing Type
4
Filing Date
11/26/2024
Updated
11/27/24, 3:21 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership